FDA Adverse Event Malfunction Summary report: N

THERAKOS CELLEX PHOTOPHERESIS SYSTEM

MDR report key: 2961222 · Received February 8, 2013

Report

Report Number
2523595-2013-00006
Event Type
Malfunction
Date Received
February 8, 2013
Date of Event
January 30, 2013
Report Date
January 30, 2013
Manufacturer
THERAKOS
Product Code
LNR
PMA / PMN Number
P680003
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

THE ROOT CAUSE WAS CONFIRMED BY VISUAL INSPECTION BY THE CUSTOMER TO BE A LEAK IN THE TUBING BOND JOINT OF THE PRESSURE DOME. THIS EVENT IS REPORTABLE. THE DEVICE DID NOT CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY; BUT IT MALFUNCTIONED IN A WAY THAT WOULD BE LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY, IF THE MALFUNCTION WERE TO RECURE DUE TO THE FACT THAT THIS SHARES THE SAME ROOT CAUSE AS A PREVIOUSLY REPORTED MALFUNCTION. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER CALLED TO REPORT A BLOOD LEAK ALARM THAT OCCURRED DURING A TREATMENT PROCEDURE. ISSUE STARTED ON: (B)(6) 2013. THE CUSTOMER CALLED TO REPORT BLOOD LEAKING FORM THE KIT. CUSTOMER STATED SHE OBSERVED BLOOD LEAKING FROM THE BOND JOINT OF THE COLLECT PRESSURE DOME TO THE TUBING OF THE KIT. CUSTOMER ABORTED THE TREATMENT AND DID NOT RETURN ANY BLOOD OR PRODUCTS TO PATIENT. A NEW TREATMENT WAS NOT RESTARTED. ASSOCIATE PROCEDURAL KIT: KIT TYPE: CLXUSA KIT LOT NUMBER: A328-635. CTS ASKED THE CUSTOMER TO RETURN THE KIT TO THERAKOS FOR AN INVESTIGATION AND THE CUSTOMER AGREED TO DO SO. CTS ASKED IF THERE WERE ANY ERROR DURING PRIME. CUSTOMER STATED THERE WERE NO ALARMS DURING PRIME. DRA (B)(4) HAS BEEN OPENED TO REVIEW THE CELLEX KIT THAT HAS BEEN REQUESTED FROM THE CUSTOMER SITE. TO DATE, THE KIT HAS NOT BEEN RECEIVED FROM THE CUSTOMER SITE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
53921 THERAKOS CELLEX PHOTOPHERESIS SYSTEM CELLEX ECP SYSTEM LNR THERAKOS 6661 A328

Patients

Seq Age Sex Outcome Treatment
1 70 YR